TITLE

Pazopanib active in ovarian cancer

PUB. DATE
October 2008
SOURCE
Hem/Onc Today;10/25/2008, Vol. 9 Issue 19, p18
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
The article reports on the study about Pazopanib conducted by Michael Friedlander of the department of medical oncology at Prince of Wales Hospital. A phase-2 trial data from the study shows that the investigational angiogenesis inhibitor had a significant single-agent activity in patients with ovarian cancer who relapsed after platinum chemotherapy.
ACCESSION #
34781537

 

Related Articles

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics